India And Netherlands Sign A MoU To Cooperate On Medical Product Regulation, And Enhancing The Quality

New Delhi: India and Netherlands have signed a Memorandum of Intent (MoI) to cooperate on medical product regulation and enhance the quality of medical products and healthcare services for both countries at Hague, Netherlands. The MoI was signed during a meeting of Shri Bhagwant Khuba, Union Minister of State for Chemicals and Fertilizers with Mr. Ernst Kuipers Minister of Health, Welfare and Sports of the Kingdom of Netherlands.

An Indian delegation led by Shri Khuba is in Netherlands to participate in the second World Local Production Forum (WLPF) meeting being held in The Hague from 6 to 8 November 2023. The World Local Production Platform is a platform created at the initiative of WHO with the aim of increasing access to medicines and other health technologies.

The Minister also visited the European Medicines Agency (EMA). He met Ms. Carla van Rooijen, Director of the Pharmaceuticals and Medical Technology Division and had a fruitful discussion with her about regulations in the pharmaceutical and medical technology industries.

During his visit Shri Khuba visited the Port of Rotterdam, Europe’s largest port and discussed with Mr. Boudwijn Simmons, COO and other officials about the port’s hydrogen hub plans. Rotterdam is poised to become a hub in hydrogen production and transportation. He also shared India’s Green Hydrogen Mission and India’s aim to become a global leader in Green Hydrogen under the able leadership of Prime Minister.

Shri Khuba also visited Bilthoven Biologicals (Cyrus Poonawalla Group) world’s largest vaccine producer.

Related Posts

  • Pharma
  • September 7, 2024
  • 123 views
Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

Coimbatore: A special team of the Coimbatore City Police has arrested a Haryana-based drug distributor on charges of supplying prescription drugs to peddlers in Coimbatore. The police said that Sachin Garg,…

  • Pharma
  • September 7, 2024
  • 100 views
Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Maryland: Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urinary tract infections (uUTIs) in more than two decades, the FDA is weighing the pros and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

Haryana-Based Drug Dist. Arrested For Supplying Prescription Drugs To Coimbatore Peddlers

People with Spinal Injuries are left to fend for themselves in India

People with Spinal Injuries are left to fend for themselves in India

Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Inappropriate Use Of ‘Sulopenem’ Could Cause Antimicrobial Resistance (AMR)

Medical Shop Owner Faces Charges For Drug Money Laundering In Punjab

Medical Shop Owner Faces Charges For Drug Money Laundering In Punjab

Narayana Health is poised to transform Nurses Skills to enhance Patient Outcomes

Narayana Health is poised to transform Nurses Skills to enhance Patient Outcomes

DCGI Seeks Explanation From Entod Pharma Claiming Eye Drops Can Cure Eyesight

DCGI Seeks Explanation From Entod Pharma Claiming Eye Drops Can Cure Eyesight